The news of Piper Sandler maintaining an Overweight rating on Natera indicates a positive outlook for the company. However, the lowering of the price target from $80 to $70 may create some uncertainty among investors. The short-term impact on NTRA's stock price is expected to be neutral as the positive rating is offset by the reduced price target.